Afuco™ Anti-Human CSF1 ADCC Theraputic Antibody (PD-0360324), ADCC Enhanced

Anti-CSF1 ADCC Enhanced Antibody (PD-0360324) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel neutralizing human monoclonal antibody against monocyte/ macrophage colony stimulating factor (M-CSF). It exhibited a nonlinear PK profile associated with rapid suppression of PD markers and was generally well tolerated. The safety and efficacy profile will be investigated further in a multi-dose study in patients with rheumatoid arthritis.

https://www.creativebiolabs.net/Anti-CSF1-ADCC-Enhanced-Antibody-PD-0360324-20483.htm